Cite

APA Citation

    Brose, M. S., & Singh, N. (n.d.). vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer – Authors' response. Lancet oncology, 17(11), e469–. http://access.bl.uk/ark:/81055/vdc_100038840370.0x000034
  
Back to record